Palisade Asset Management LLC grew its holdings in UnitedHealth Group Inc (NYSE:UNH) by 20.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 69,959 shares of the healthcare conglomerate’s stock after buying an additional 11,777 shares during the period. UnitedHealth Group accounts for about 2.4% of Palisade Asset Management LLC’s holdings, making the stock its 8th biggest holding. Palisade Asset Management LLC’s holdings in UnitedHealth Group were worth $15,423,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Exane Derivatives grew its holdings in shares of UnitedHealth Group by 15,333.3% in the fourth quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock valued at $102,000 after purchasing an additional 460 shares during the period. Bruderman Asset Management LLC purchased a new stake in shares of UnitedHealth Group in the second quarter valued at about $114,000. Acrospire Investment Management LLC grew its holdings in shares of UnitedHealth Group by 130.7% in the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after purchasing an additional 400 shares during the period. Jacobi Capital Management LLC grew its holdings in shares of UnitedHealth Group by 6.6% in the second quarter. Jacobi Capital Management LLC now owns 729 shares of the healthcare conglomerate’s stock valued at $136,000 after purchasing an additional 45 shares during the period. Finally, Baystate Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 64.9% in the fourth quarter. Baystate Wealth Management LLC now owns 762 shares of the healthcare conglomerate’s stock valued at $186,000 after purchasing an additional 300 shares during the period. Institutional investors and hedge funds own 86.83% of the company’s stock.

How to Become a New Pot Stock Millionaire

UnitedHealth Group Inc (NYSE UNH) opened at $226.94 on Wednesday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. UnitedHealth Group Inc has a 12 month low of $162.74 and a 12 month high of $250.79. The company has a market cap of $219,600.00, a P/E ratio of 23.89, a PEG ratio of 1.31 and a beta of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. During the same quarter last year, the firm posted $2.11 earnings per share. The business’s revenue for the quarter was up 9.5% compared to the same quarter last year. sell-side analysts expect that UnitedHealth Group Inc will post 12.51 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th will be paid a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.32%. The ex-dividend date of this dividend is Thursday, March 8th. UnitedHealth Group’s payout ratio is 31.58%.

In other news, CEO Larry C. Renfro sold 22,598 shares of the firm’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $221.75, for a total value of $5,011,106.50. Following the completion of the transaction, the chief executive officer now owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Kenneth Irwin Shine sold 198 shares of the firm’s stock in a transaction that occurred on Friday, January 19th. The shares were sold at an average price of $242.55, for a total transaction of $48,024.90. Following the completion of the transaction, the director now directly owns 1,790,567 shares of the company’s stock, valued at approximately $434,302,025.85. The disclosure for this sale can be found here. In the last three months, insiders sold 53,196 shares of company stock valued at $12,291,179. Insiders own 0.89% of the company’s stock.

A number of brokerages recently issued reports on UNH. Credit Suisse Group reissued a “buy” rating on shares of UnitedHealth Group in a report on Friday, March 9th. Wells Fargo & Co reissued an “outperform” rating and issued a $245.00 price objective (up previously from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Citigroup upped their price objective on shares of UnitedHealth Group from $235.00 to $268.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Oppenheimer upped their price objective on shares of UnitedHealth Group from $260.00 to $240.00 and gave the company an “outperform” rating in a report on Wednesday, January 17th. Finally, Piper Jaffray Companies upped their price objective on shares of UnitedHealth Group to $242.00 and gave the company an “overweight” rating in a report on Wednesday, November 29th. Two research analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $245.14.

TRADEMARK VIOLATION WARNING: “UnitedHealth Group Inc (UNH) Shares Bought by Palisade Asset Management LLC” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this article on another publication, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this article can be viewed at https://www.dailypolitical.com/2018/03/14/unitedhealth-group-inc-unh-shares-bought-by-palisade-asset-management-llc.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.